AQUESTIVE THERAPEUTICS INC. - COMMON STOCK

3.3000

06-January-25 15:45:00

15 minutes delayed

Stocks

-0.2800

-7.82%

Today's range

3.2600 - 3.5900

ISIN

N/A

Source

NASDAQ

Aquestive Therapeutics to Announce Fourth Quarter and Year End 2020 Financial Results and Recent Business Highlights on March 9 and Host Conference Call on March 10 at 8:00 a.m. ET

17 Feb 2021 06:30:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

09 Feb 2021 06:30:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy

28 Jan 2021 06:30:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics Provides Business Update

07 Jan 2021 06:30:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences

04 Jan 2021 06:30:00 By Nasdaq GlobeNewswire

<<
<
3
4
5
6
7
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.